4/2016 |
Series C |
|
$16.4M |
Seventure Partners
Lundbeckfond Ventures
Nestle health science
|
7/2022 |
Series F |
|
$20.1M |
|
6/2020 |
Series E |
6 |
$51.9M |
Health for Life Capital fund
Nestlé Health Science
Omnes Capital
Principia SGR
Seventure Partners
Takeda
Health for Life Capital fund
Nestlé Health Science
Omnes Capital
Principia SGR
Seventure Partners
Takeda
|
1/2011 |
Seed Round |
2 |
$2M |
INRA
Seventure Partners
|
3/2012 |
Series A |
|
$0 |
Lundbeckfonden Ventures
Seventure Partners
Shire
Omnes Capital
Lundbeckfonden Ventures
Seventure Partners
Shire
Omnes Capital
|
1/2018 |
Series D |
|
$38.5M |
Seventure
Omnes Capital
LundbeckFonden Ventures
Nestlé Health Science
Principia SGR
Bristol-Myers Squibb
|
6/2020 |
Series E |
|
$52.6M |
SymBiosis, LLC
Takeda Pharmaceutical Company Limited
Seventure
Principia
Omnes Capital
Nestlé Health Science
|
2/2012 |
Series A |
|
$5M |
Lundbeckfond Ventures
Seventure Partners
|
4/2014 |
Series B |
|
$13.8M |
Seventure Partners
Lundbeckfond Ventures
Omnes Capital
|
1/2017 |
Series D |
7 |
$33.4M |
Seventure Partners
Nestlé Health Science
Principia SGR
Omnes Capital
Lundbeckfonden Ventures
Health for Life Capital fund
Bristol Myers Squibb
Seventure Partners
|
1/2018 |
Debt Financing |
8 |
- |
Lundbeckfonden Ventures
Principia SGR
Nestlé Health Science
Seventure Partners
European Investment Bank
Bristol Myers Squibb
Health for Life Capital fund
Omnes Capital
Lundbeckfonden Ventures
Principia SGR
Nestlé Health Science
Seventure Partners
European Investment Bank
Bristol Myers Squibb
Health for Life Capital fund
Omnes Capital
|
5/2014 |
Series B |
3 |
$15.3M |
Seventure Partners
Omnes Capital
Lundbeckfonden Ventures
Seventure Partners
|
4/2016 |
Series C |
5 |
$16.4M |
Lundbeckfonden Ventures
Seventure Partners
Nestlé Health Science
Omnes Capital
Health for Life Capital fund
Lundbeckfonden Ventures
Seventure Partners
|
1/2018 |
Debt Financing |
8 |
- |
Lundbeckfonden Ventures
Principia SGR
Nestlé Health Science
Seventure Partners
European Investment Bank
Lundbeckfonden Ventures
Principia SGR
Nestlé Health Science
Seventure Partners
European Investment Bank
|
3/2012 |
Series A |
4 |
$9.9M |
Lundbeckfonden Ventures
Seventure Partners
Lundbeckfonden Ventures
Seventure Partners
|